´óÏó´«Ã½

Home
EBV-MS

EBV-MS in the Media

News stories involving the EBV-MS project.

Main content

Date, media outlet, title, and the individual interviewed or referred to in relation to EBV-MS.

2025

April 25, Ellipse ""ÌýJordi Rambla and Amy CurwinÌýÌý(EGA from CRG);ÌýArcadi Navarro (UPF/CRG); Gabriel Santpere (IMIM)ÌýPablo Villoslada (UPF/IMIM) and Jordi Garcia-Ojalvo (UPF).Ìý

2024

April 16, HealthTalk on MS research in Norway.

April 24, 2024, KK: "." Øivind Torkildsen.

February 29, 2024, UiB News: "Forsker på mulig ny MS-medisin." Øivind Torkildsen.

February 28, 2024, the Economist: "."Ìý

February 21, 2024, Forskning.no: "" Øivind Torkildsen.

February 3, 2024, NeurologyLive: "." Øivind Torkildsen.

January 8, 2024, Dagbladet: ""Ìý

MedHub.no, "", Øivind Torkildsen, Kjell-Morten Myhr.

2023

September 22, 2023, Dagens Medisin: "." Kjell-Morten Myhr, Øivind Torkildsen.

EBV-MS in Social Media

Social media is an essential instrument in amplifying the promotional impact of the project's communication activities. It serves as a pivotal tool for engaging with third parties, the research community, and the public alike. Through platforms such as Facebook, Instagram, Twitter and LinkedIn, The EBV-MS project will promote project results and milestones, as well as provide news updates, happenings, and media appearances. We use the established social media channels of each consortium member's respective institutions to engage with a broader and well-established audience. ÌýThe hashtags we use include: #EBVMS #MultipleSclerosis #MS

Check out our main social media channels for UiB and EMSP below. Follow us to stay updated!

UiB

¹ó²¹³¦±ð²ú´Ç´Ç°ì:Ìý and

Instagram:

°Õ·É¾±³Ù³Ù±ð°ù:Ìý and

³¢¾±²Ô°ì±ð»å±õ²Ô:Ìý

³Û´Ç³Ü°Õ³Ü²ú±ð:Ìý and
Ìý

EMSP

¹ó²¹³¦±ð²ú´Ç´Ç°ì:Ìý

Instagram:Ìý

Twitter:

³¢¾±²Ô°ì±ð»å±õ²Ô:Ìý

³Û´Ç³Ü°Õ³Ü²ú±ð:Ìý

Ìý

Ìý